David Donabedian

Founding CEO

Boston, Massachusetts, United States

32 investments

David Donabedian is a Founding CEO at Newleos Therapeutics based in Boston, Massachusetts, United States. David Donabedian has backed 32 companies, including Lassen Therapeutics, Pulmocide and Mitobridge. Investment focus areas include Health Care, Wellness and Women Founded.

Investment Focus

Media and Entertainment

Personal Health

Pharmaceuticals

Portfolio Companies (34)


1	Lassen Therapeutics
2	Pulmocide
3	Mitobridge
4	Verastem Oncology
5	Alnara Pharmaceuticals
6	Colorescience
7	Alcyone Therapeutics Inc.
8	Calithera Biosciences
9	Bicycle Therapeutics
10	PTC Therapeutics
11	Flex Pharma
12	Anuncia Inc

Showing 1–12 of 34

Page 1 of 3

Access Full Contact Information

Get David Donabedian's email, LinkedIn, Twitter, full portfolio of investments, and export data to CSV.

Portfolio

3-day free trial, cancel anytime

Raising a round? Run your numbers first

Free tools founders use before pitching investors like this one.

Runway calculatorHow long your cash lasts Burn rate calculatorMonthly spend, gross and net Funding goal calculatorHow much to raise Investor ROI calculatorWhat your investors earn Pitch deck template11 slides that close Fundraising playbookThe 7-step raise process